Skip to content

A simple autofluorescence tool to measure glycoalbumin level in diabetic patients

Autofluorescence based diagnostic technique for measuring Glycoalbumin, a potential marker for glycemic control in diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/05/033638
Enrollment
114
Registered
2021-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E086- Diabetes mellitus due to underlying condition with other specified complications

Interventions

Intervention1: NIL: NIL Intervention2: blood draw using needle: Four millilitre of blood will be drawn using five millilitre disposable needle for fluorescence assessment of glycoalbumin. Since the cu

Sponsors

Indian Council of Medical Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Control and Diabetic subjects with or without diabetic complications (neuropathy, nephropathy, atherosclerosis) willing to provide blood will be included in the study. For conducting our study, the blood samples of the participants will be collected as provided by the clinical collaborator from Department of Medicine, Kasturba Hospital, Manipal,

Exclusion criteria

Exclusion criteria: Individuals with communicable diseases will be excluded from the study

Design outcomes

Primary

MeasureTime frame
a new diagnostic tool of glycoalbumin measuremnt will be developed Timepoint: The blood (4 ml) from each clinical participants will be drawn only one time during the study.

Secondary

MeasureTime frame
The study has transnational potentialTimepoint: 2 year

Countries

India

Contacts

Public ContactDr Vijendra Prabhu

Manipal Academy of Higher Education

darshancm46@gmail.com9686259285

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026